Tunis El Manar University, Faculty of Medicine of Tunis, LR18ES39, 1006,
Search for other papers by Yosra Chebbi in
Current site
Google Scholar
PubMed
Tunis El Manar University, Faculty of Medicine of Tunis, LR18ES39, 1006,
Search for other papers by Siwar Frigui in
Current site
Google Scholar
PubMed
Tunis El Manar University, Faculty of Medicine of Tunis, LR18ES39, 1006,
Search for other papers by Anis Raddaoui in
Current site
Google Scholar
PubMed
Search for other papers by Dorra Belloumi in
Current site
Google Scholar
PubMed
Search for other papers by Amel Lakhal in
Current site
Google Scholar
PubMed
Search for other papers by Lamia Torjemane in
Current site
Google Scholar
PubMed
Search for other papers by Nour Ben Abeljelil in
Current site
Google Scholar
PubMed
Search for other papers by Saloua Ladeb in
Current site
Google Scholar
PubMed
Search for other papers by Tarek Ben Othmen in
Current site
Google Scholar
PubMed
Search for other papers by Rym El Fatmi in
Current site
Google Scholar
PubMed
Tunis El Manar University, Faculty of Medicine of Tunis, LR18ES39, 1006,
Search for other papers by Wafa Achour in
Current site
Google Scholar
PubMed
Abstract
The purpose of our study was to investigate the epidemiology of coagulase negative staphylococci (CoNS) responsible for bacteremia in hematopoietic stem cell transplant (HSCT) recipients and to determine the prevalence and the genetic background of methicillin resistance. The prevalence of CoNS bacteremia was 7.4% (54/728), higher in allograft (10.7%) than in autograft (4.7%) recipients. A sepsis or a septic shock were observed in 9% of cases. No deaths were attributable to CoNS bacteremia. The methicillin resistance rate was 81%. All MR-CoNS, harbored mecA gene and 90% were typeable with SCCmec typing using PCR amplification. The SCCmec type IV was the most frequent (44%). Clonal dissemination of MR- Staphylococcus epidermidis strains was limited. Our study showed a low prevalence and favorable outcome of CoNS bacteremia in HSCT recipients with limited clonal diffusion. However, they were associated with a significant rate of severe infections and a high rate of methicillin resistance, mediated by SCCmec IV element in most cases.
-
[1]
Attman E, Aittoniemi J, Sinisalo M, Vuento R, Lyytikainen O, Karki T, et al. Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma 2015; 56(12): 3370–7. https://doi.org/10.3109/10428194.2015.1032967.
-
[2]
Barbier F. Staphylocoques à coagulase négative: quand, comment et pourquoi sont-ils responsables d’infections ? J Anti-Infect 2015; 17(1): 15–19. https://doi.org/10.1016/j.antinf.2015.01.001.
-
[3]
Costa SF, Barone AA, Miceli MH, Van Der Heijden IM, Soares RE, Levin AS, et al. Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study. Am J Infect Control 2006; 34(1): 36–40. https://doi.org/10.1016/j.ajic.2005.10.007.
-
[4]
Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev 2014; 27(4): 870–926. https://doi.org/10.1128/CMR.00109-13.
-
[5]
Société Française de Microbiologie. REMIC : Référentiel en microbiologie médicale. 5ème édition. Paris: Société Française de Microbiologie; 2015.
-
[6]
Comité de l'Antibiogramme de La Société Française de Microbiologie. Recommandations 2019 V.1.0 Janvier. Paris: Société Française de Microbiologie; 2019.
-
[7]
Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43(10): 5026–33. https://doi.org/10.1128/JCM.43.10.5026-5033.2005.
-
[8]
Katayama Y, Ito T, Hiramatsu K. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus. Antimicrob Agents Chemother 2001; 45(7): 1955–63. https://doi.org/10.1128/JCM.43.10.5026-5033.2005.
-
[9]
Oliveira DC, Milheirico C, de Lencastre H. Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI. Antimicrob Agents Chemother 2006; 50(10): 3457–9. https://doi.org/10.1128/AAC.00629-06.
-
[10]
Chung M, De Lencastre H, Matthews P, Tomasz A, De Sousa MA, Camou T, et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist 2000; 6(3): 189–98. https://doi.org/10.1089/mdr.2000.6.189.
-
[11]
Gudiol C, Garcia-Vidal C, Arnan M, Sanchez-Ortega I, Patino B, Duarte R, et al. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients. Bone Marrow Transpl 2014; 49(6): 824–30. https://doi.org/10.1038/bmt.2014.37.
-
[12]
Frere P, Hermanne JP, Debouge MH, De Mol P, Fillet G, Beguin Y. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transpl 2004; 33(7): 745–9. https://doi.org/10.1038/sj.bmt.1704414.
-
[13]
Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transpl 2009; 15(1): 47–53. https://doi.org/10.1016/j.bbmt.2008.10.024.
-
[14]
Cluff LE, Reynolds RC, Page DL, Breckenridge JL. Staphylococcal bacteremia and altered host resistance. Ann Intern Med 1968; 69(5): 859–73. https://doi.org/10.7326/0003-4819-69-5-859.
-
[15]
Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis [en ligne] 2015 juillet [11/05/2019]; 7(1): [13 pages]. https://doi.org/10.4084/MJHID.2015.045.
-
[16]
Tacconelli E, D'Agata EMC, Karchmer AW. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission. Clin Infect Dis 2003; 37(5): 644–9. https://doi.org/10.1086/377207.
-
[17]
Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev 2014; 27(4): 870–926. https://doi.org/10.1128/CMR.00109-13.
-
[18]
Bertrand X, Lallemand S, Thouverez M, Boisson K, Talon D. Bactériémies liées aux staphylocoques à coagulase négative: incidence, niveau de résistance à la teicoplanine et épidémiologie moléculaire. Pathol Biol 2002; 50(9): 552–9. https://doi.org/10.1016/S0369-8114(02)00347-4.
-
[19]
Timsit JF. Updating of the 12th consensus conference of the Societe de Reanimation de langue francaise (SRLF): catheter related infections in the intensive care unit. Ann Fr Anesth Reanim 2005; 24(3): 315–22. https://doi.org/10.1016/S0369-8114(02)00347-4.
-
[20]
Cherifi S, Byl B, Deplano A, Nonhoff C, Denis O, Hallin M. Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers. J Clin Microbiol 2013; 51(5): 1541–7. https://doi.org/10.1128/JCM.03378-12.
-
[21]
Yamada K, Namikawa H, Fujimoto H, Nakaie K, Takizawa E, Okada Y, et al. Clinical characteristics of methicillin-resistant coagulase-negative staphylococcal bacteremia in a tertiary hospital. Intern Med 2017; 56(7): 781–5. https://doi.org/10.2169/internalmedicine.56.7715.
-
[22]
Ben Hassen A, Gréco A, Jouaihia W, Leclercq R. Profil épidémiologique des souches de Staphylococcus epidermidis méticilline résistant de sensibilité diminuée à la teicoplanine et isolées chez des patients neutropéniques au Centre National de Greffe de Moelle Osseuse à Tunis. Pathol Biol 2001; 49(8): 634–40. https://doi.org/10.1016/S0369-8114(01)00222-X.
-
[23]
García P, Benítez R, Lam M, Salinas AM, Wirth H, Espinoza C, et al. Coagulase-negative staphylococci: clinical, microbiological and molecular features to predict true bacteremia. J Med Microbiol 2004; 53(1): 67–72. https://doi.org/10.1099/jmm.0.04994-0.
-
[24]
Karakullukçu A, Kuşkucu M A, Ergin S, Aygün G, Midilli K, Küçükbasmaci Ö. Determination of clinical significance of coagulase-negative staphylococci in blood cultures. Diag Microbiol Infect Dis 2017; 87: 291–294. https://doi.org/10.1016/j.diagmicrobio.2016.12.006.
-
[25]
Puerta-Alcalde P, Cardozo C, Suarez-Lled M, Rodríguez-Nú∼nez O, Morata L, Feher C et al. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect 2018; 25: 447–453. https://doi.org/10.1016/j.cmi.2018.07.026.
-
[26]
Morioka S, Ichikawa M, Mori K, Kurai H. Coagulase-negative staphylococcal bacteraemia in cancer patients. Time to positive culture can distinguish bac-teraemia from contamination. Inf Dis 2018; 50(9): 660–5. https://doi.org/10.1016/j.cmi.2018.07.0260.
-
[27]
Lafaurie M, Jaureguy F, Lefort A, Lesprit P, Mainardi JL. Prescriptions of glycopeptides in 10 university hospitals in Paris area: a 1-day survey. Rev Med Interne 2011; 32(3): 149–53. https://doi.org/10.1016/j.revmed.2010.09.022.
-
[28]
Stahl J-P. Actualités sur les infections sévères à gram positif. Médecine Mal Infect 2010; 40(Suppl. 9): H1–H6. https://doi.org/10.1016/S0399-077X(10)70002-0.
-
[29]
Fantin B. Les nouveaux antistaphylococciques. Ann Fr Anesth Réanimation 2002; 21(5): 424–30. https://doi.org/10.1016/S0750-7658(02)00630-5.
-
[30]
Miragaia M, Thomas JC, Couto I, Enright MC, De Lencastre H. Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J Bacteriol 2007; 189(6): 2540–52. https://doi.org/10.1016/S0750-7658(02)00630-5.
-
[31]
Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, et al. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. J Antimicrob Chemother 2013; 68(Suppl. 1): I7–I22. https://doi.org/10.1016/S0750-7658(02)00630-5.
-
[32]
Mendes RE, Sader HS, Jones RN. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007–2008). Int J Antimicrob Agents 2010; 36(4): 374–9. https://doi.org/10.1016/j.ijantimicag.2010.05.016.
-
[33]
Jemili-Ben Jomaa M, Boutiba-Ben Boubaker I, Ben Redjeb S. Identification of staphylococcal cassette chromosome mec encoding methicillin resistance in Staphylococcus aureus isolates at Charles Nicolle Hospital of Tunis. Pathol Biol (Paris) 2006; 54(8–9): 453–5. https://doi.org/10.1016/j.patbio.2006.07.013.
-
[34]
Mastouri M, Nour M, Ben Nejma M, Bouallegue O, Hammami M, Khedher M. Antibiotics resistance of meticilline-resistant Staphylococcus aureus: detection of the first glycopeptides low sensibility strains in Tunisia. Pathol Biol (Paris) 2006; 54(1): 33–6. https://doi.org/10.1016/j.patbio.2004.10.009.
-
[35]
Ben Nejma M, Mastouri M, Frih S, Sakly N, Ben Salem Y, Nour M. Molecular characterization of methicillin-resistant Staphylococcus aureus isolated in Tunisia. Diagn Microbiol Infect Dis 2006; 55(1): 21–6. https://doi.org/10.1016/j.diagmicrobio.2005.10.017.
-
[36]
Gordon RJ, Miragaia M, Weinberg AD, Lee CJ, Rolo J, Giacalone JC, et al. Staphylococcus epidermidis colonization is highly clonal across US cardiac centers. J Infect Dis 2012; 205(9): 1391–8. https://doi.org/10.1093/infdis/jis218.
-
[37]
Muldrew KL, Tang YW, Li H, Stratton CW. Clonal dissemination of Staphylococcus epidermidis in an oncology ward. J Clin Microbiol. 2008; 46(10): 3391–6. https://doi.org/10.1128/JCM.00115-08.
-
[38]
Cimiotti JP, Wu F, Della-Latta P, Nesin M, Larson E. Emergence of resistant staphylococci on the hands of new graduate nurses. Infect Control Hosp Epidemiol 2004; 25(5): 431–5. https://doi.org/10.1086/502418.
Please, download the file from HERE
Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary
Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- Chemical Abstracts
- Global Health
- Index Medicus
- Index Veterinarius
- Medline
- Referativnyi Zhurnal
- SCOPUS
- Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 1.3 |
| Rank by Impact Factor | Q4 (Immunology) |
| Journal Citation Indicator | 0.31 |
| Scopus | |
| CiteScore | 2.3 |
| CiteScore rank | Q3 (Infectious Diseases) |
| SNIP | 0.389 |
| Scimago | |
| SJR index | 0.308 |
| SJR Q rank | Q3 |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article (only for OA publications) |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 772 EUR / 848 USD Print + online subscription: 860 EUR / 944 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
1954 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1217-8950 (Print) |
| ISSN | 1588-2640 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Mar 2024 | 83 | 0 | 0 |
| Apr 2024 | 34 | 0 | 0 |
| May 2024 | 37 | 0 | 0 |
| Jun 2024 | 62 | 1 | 3 |
| Jul 2024 | 55 | 0 | 0 |
| Aug 2024 | 56 | 0 | 0 |
| Sep 2024 | 5 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.